Patents by Inventor Mark Edward STELLA
Mark Edward STELLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11433030Abstract: A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.Type: GrantFiled: December 16, 2019Date of Patent: September 6, 2022Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Anness, Guhan Balan, Andrew Nicholas Carr
-
Publication number: 20200113841Abstract: A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.Type: ApplicationFiled: December 16, 2019Publication date: April 16, 2020Inventors: Mark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Aness, Guhan Balan, Andrew Nicholas Carr
-
Patent number: 10617714Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: GrantFiled: May 9, 2019Date of Patent: April 14, 2020Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Patent number: 10576041Abstract: A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.Type: GrantFiled: September 25, 2017Date of Patent: March 3, 2020Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Aness, Guhan Balan, Andrew Nicholas Carr
-
Publication number: 20190262392Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: May 9, 2019Publication date: August 29, 2019Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Patent number: 10322144Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: GrantFiled: June 22, 2018Date of Patent: June 18, 2019Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Publication number: 20180296592Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: June 22, 2018Publication date: October 18, 2018Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Patent number: 10028977Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: GrantFiled: April 10, 2017Date of Patent: July 24, 2018Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Publication number: 20180085317Abstract: A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.Type: ApplicationFiled: September 25, 2017Publication date: March 29, 2018Inventors: Mark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Aness, Guhan Balan, Andrew Nicholas Carr
-
Patent number: 9827203Abstract: The invention is associated with ingestible film coated solid dosage forms comprising natural honey in the coating applied to such forms. The natural honey of the film coated solid dosage form is of sufficient level to be perceived by the user while avoiding sticking to each other or the packaging with which they are in contact and, or storage.Type: GrantFiled: July 25, 2016Date of Patent: November 28, 2017Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, Elissa Nicole Knights
-
Publication number: 20170209487Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: April 10, 2017Publication date: July 27, 2017Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Patent number: 9649274Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: GrantFiled: May 19, 2015Date of Patent: May 16, 2017Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Publication number: 20160331690Abstract: The invention is associated with ingestible film coated solid dosage forms comprising natural honey in the coating applied to such forms. The natural honey of the film coated solid dosage form is of sufficient level to be perceived by the user while avoiding sticking to each other or the packaging with which they are in contact and, or storage.Type: ApplicationFiled: July 25, 2016Publication date: November 17, 2016Inventors: Mark Edward Stella, Elissa Nicole Knights
-
Patent number: 9421171Abstract: The invention is associated with ingestible film coated solid dosage forms comprising natural honey in the coating applied to such forms. The natural honey of the film coated solid dosage form is of sufficient level to be perceived by the user while avoiding sticking to each other or the packaging with which they are in contact and, or storage.Type: GrantFiled: February 13, 2012Date of Patent: August 23, 2016Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, Elissa Nicole Knights
-
Patent number: 9351939Abstract: The invention is associated with ingestible film coated solid dosage forms comprising natural honey in the coating applied to such forms. The natural honey of the film coated solid dosage form is of sufficient level to be perceived by the user while avoiding sticking to each other or the packaging with which they are in contact and, or storage.Type: GrantFiled: August 14, 2013Date of Patent: May 31, 2016Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, Elissa Nicole Knights
-
Publication number: 20150283064Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: May 19, 2015Publication date: October 8, 2015Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Publication number: 20150250712Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: May 19, 2015Publication date: September 10, 2015Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Patent number: 9005635Abstract: A personal health care article. More particularly, a personal health care article comprising at least one porous disintegratable solid substrate comprising: from about 1% to about 70%, by weight of said substrate, of a surfactant, from about 10% to about 70%, by weight of said substrate, of one or more polymers, from about 0.025% to about 85%, by weight of said substrate, of one or more health care actives, optionally a plasticizer, and optionally an aesthetic agent wherein said article is ingestible. The invention also comprises a process for making a personal health care article.Type: GrantFiled: March 1, 2012Date of Patent: April 14, 2015Assignee: The Procter & Gamble CompanyInventors: Trevor John Darcy, Steven Ray Gilbert, Robert Wayne Glenn, Jr., Mark Edward Stella
-
Publication number: 20150050416Abstract: The invention is associated with ingestible film coated solid dosage forms comprising natural honey in the coating applied to such forms. The natural honey of the film coated solid dosage form is of sufficient level to be perceived by the user while avoiding sticking to each other or the packaging with which they are in contact and, or storage.Type: ApplicationFiled: August 14, 2013Publication date: February 19, 2015Applicant: The Procter & Gamble CompanyInventors: Mark Edward Stella, Elissa Nicole Knights
-
Publication number: 20140371174Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: June 12, 2013Publication date: December 18, 2014Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louie Naykki